Delivery Order SPE2DB25D3108-SPE2DB25FPDBY

Award Date 6/11/25
Potential Completion Date 6/12/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Estradiol 0.06% 1.25g Gel Pump 37.5g. The contract has a ceiling value of $1,134.24 and a completion date of January 14, 2025. It is a firm fixed-price contract, and no set-aside designation was used. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Estradiol 0.06% 1.25g gel pump. The award, valued at $1,193.22, is a firm fixed-price delivery order contract with an ultimate completion date of December 23, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,938.68, is for the delivery of Estradiol 0.06% 1.25G Gel Pump, 37.5GM. It is a firm-fixed-price delivery order contract with a completion date of January 24, 2025. The contract is not designated as a set-aside and was competitively awarded. Amerisourcebergen holds a larger $999,999,999...
This is a $1,089.30 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of a 37.5 gram pump of 0.06% estradiol gel. The award is not designated as a set-aside and is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical worth up to $999,999,999 through November 2026. This...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Estradiol 0.1% (0.25mg) gel in packs of 30, with a ceiling value of $1,366.26 and a completion date of June 23, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
The federal contract award SPE2DB20D1110|SPE2DB24FK54L was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 37.5 gram pumps of 0.06% estradiol gel. The $1,933.33 firm-fixed-price delivery order has a completion date of September 18, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a larger indefinite delivery contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,478.05, is for the supply of Estradiol 0.01% Cream, a medication used in the treatment of certain medical conditions. The contract is a Firm Fixed Price Delivery Order with a completion date of March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Estradiol 0.01% cream in a 42.5 gram size. The firm-fixed-price contract has a ceiling value of $2,978.04 and is set to expire on September 24, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this order as a part of its larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Estradiol 0.01% Cream (42.5 grams). The $1,133.67 firm fixed-price delivery order contract has an ultimate completion date of July 20, 2022. This contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop...
This firm fixed price delivery order, valued at $164.88, was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation for the supply of 0.1% estradiol gel. The place of performance is Conshohocken, Pennsylvania and the period of performance is July 21-24, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor. No major subcontractors or set aside designations were indicated. The Defense...
  • SPE2DB25D3108
    Indefinite Delivery Contract
  • SPE2DB25D3108-SPE2DB25FPDBY
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Estradiol 0.06% 1.25g gel pump, 37.5g in Conshohocken, Pennsylvania. The award has a ceiling value of $1,723.82 and a completion date of June 12, 2025. The contract is not designated as a set-aside.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/14/25, 12:55 AM